![]() |
Volumn 88, Issue 2, 2002, Pages 163-165
|
II. Rapacuronium: Why did it fail as a replacement for succinylcholine?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLYCOPYRRONIUM BROMIDE;
MIVACURIUM;
NEOSTIGMINE;
NEUROMUSCULAR BLOCKING AGENT;
RAPACURONIUM BROMIDE;
ROCURONIUM;
SUXAMETHONIUM;
DRUG DERIVATIVE;
RAPACURONIUM;
VECURONIUM;
AMBULATORY SURGERY;
ANESTHESIST;
ANESTHETIC RECOVERY;
BRONCHOSPASM;
CONTROLLED STUDY;
DRUG COST;
DRUG MARKETING;
DRUG SAFETY;
EDITORIAL;
ENDOTRACHEAL INTUBATION;
HEALTH CARE PLANNING;
HEALTH CARE QUALITY;
HEART ARRHYTHMIA;
HUMAN;
HYPERKALEMIA;
MALIGNANT HYPERTHERMIA;
MYALGIA;
OUTPATIENT;
PATIENT CARE;
PERIOPERATIVE PERIOD;
PHARMACY;
POSTOPERATIVE NAUSEA AND VOMITING;
PRIORITY JOURNAL;
SIDE EFFECT;
UNITED STATES;
XEROSTOMIA;
CHEMICALLY INDUCED DISORDER;
AMBULATORY SURGICAL PROCEDURES;
BRONCHIAL SPASM;
HUMANS;
NEUROMUSCULAR NONDEPOLARIZING AGENTS;
SUCCINYLCHOLINE;
VECURONIUM BROMIDE;
|
EID: 0036007928
PISSN: 00070912
EISSN: None
Source Type: Journal
DOI: 10.1093/bja/88.2.163 Document Type: Editorial |
Times cited : (22)
|
References (25)
|